Free Trial

Greenbrook TMS Q1 2024 Earnings Report

$0.01 -0.01 (-35.29%)
(As of 12/20/2024 05:18 PM ET)

Greenbrook TMS Earnings Headlines

70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!
Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
See More Greenbrook TMS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Greenbrook TMS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Greenbrook TMS and other key companies, straight to your email.

About Greenbrook TMS

Greenbrook TMS (NASDAQ:GBNHF), together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders. The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

View Greenbrook TMS Profile

More Earnings Resources from MarketBeat

Upcoming Earnings